Clinical Trials

Phase 4 Active not recruiting

Multiple Myeloma, Neoplasms, Recurrence

NCT03829371 2025-12-03

STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

450 enrolled

Multiple Myeloma

NCT05511428 2025-11-21

Home Based Daratumumab Administration for Patients With Multiple Myeloma

20 enrolled 38 charts

Multiple Myeloma

NCT07025005 2025-11-04

VRd MM Fibrate

Phase 4 Recruiting

44 enrolled

Phase 4 Not yet recruiting

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

NCT07191379 2025-09-24

SCILLA

50 enrolled

Phase 4 Active not recruiting

Multiple Myeloma

NCT07154537 2025-09-04

Pneumococcal Conjugated Vaccine 13 (PCV13) for Patients With Multiple Myeloma (MM)

101 enrolled

Multiple Myeloma

NCT06409702 2025-06-12

Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection

Phase 4 Recruiting

59 enrolled

Multiple Myeloma

NCT05555329 2025-04-22

POMAlternative

12 enrolled

Multiple Myeloma

NCT04080531 2025-02-28

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

165 enrolled 9 charts

Phase 4 Not yet recruiting

Neoplasms, Plasma Cell

NCT05944783 2025-02-12

BE-Dasatinib

46 enrolled

Multiple Myeloma

NCT03768960 2025-02-03

A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent

150 enrolled

Multiple Myeloma

NCT04217967 2024-08-01

Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients

211 enrolled

Multiple Myeloma

NCT06425276 2024-05-23

Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation

67 enrolled

Multiple Myeloma

NCT00733538 2024-04-12

IFM-01-04

89 enrolled

Multiple Myeloma

NCT05545202 2024-04-03

A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation

150 enrolled

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT05855122 2023-06-02

Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients

48 enrolled

Multiple Myeloma

NCT02286830 2023-02-17

Magnolia

158 enrolled

Multiple Myeloma, Osteolysis, Osteonecrosis

NCT03619252 2022-08-31

Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents

Classical hematologyPlasma cell

36 enrolled

Multiple Myeloma, Pneumococcal Infections, Pneumonia, Pneumococcal, Febrile Neutropenia

NCT05429515 2022-06-23

Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury

Phase 4 Not yet recruiting

50 enrolled

GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

NCT05183139 2022-05-03

US MM-7

Phase 4 Withdrawn

Multiple Myeloma

NCT04989140 2021-08-19

Study of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received Lenalidomide

60 enrolled

Multiple Myeloma

NCT00622505 2021-05-26

Z-MARK

121 enrolled 15 charts

Multiple Myeloma

NCT04612582 2020-11-03

Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

70 enrolled

Immunoglobulin Light-chain Amyloidosis

NCT01087008 2020-04-06

AZABACHE

103 enrolled

Multiple Myeloma

NCT01731886 2020-02-05

Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma

60 enrolled 14 charts

Multiple Myeloma

NCT02577783 2020-02-05

PDD vs PAD to Treat Initially Diagnosed MM

64 enrolled

Multiple Myeloma

NCT02773550 2020-01-18

Velcadito

Phase 4 Terminated

24 enrolled

Multiple Myeloma

NCT02958969 2019-12-17

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Classical hematologyPlasma cell

50 enrolled 5 charts

Multiple Myeloma, Venous Thromboembolism

NCT03908138 2019-11-29

RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma

Other hematologic neoplasmPlasma cell

120 enrolled

Multiple Myeloma, Hematologic Neoplasms

NCT00003398 2019-10-17

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

45 enrolled

Anemia, Blast Crisis, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Leukemia, Leukemia, Megakaryoblastic, Acute, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating

NCT02559154 2018-05-04

Modified Bortezomib-based Combination Therapy for Multiple Myeloma

80 enrolled

Multiple Myeloma

NCT00211211 2017-12-08

FREE Study - Fracture Reduction Evaluation

300 enrolled

Plasma cellSarcoma

Back Pain, Bone Diseases, Metabolic, Bone Neoplasms, Multiple Myeloma, Osteoporosis

NCT00361140 2017-03-03

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

LymphoidMyeloidOther hematologic neoplasmPlasma cell

72 enrolled 10 charts

Leukemia, Lymphoid, Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT00434447 2017-02-27

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

BreastGenitourinaryPlasma cellSarcoma

73 enrolled

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms, Renal Insufficiency

NCT01410929 2017-01-20

MM

Phase 4 Withdrawn

Back Pain, Multiple Myeloma, Neoplasms

NCT02268890 2016-07-11

A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma

18 enrolled